Stock Research for ABIO

ABIO
Current Price

$1.6000


Latest Update: 2018-01-16 16:00:00

High
$ 1.6500
Low
$ 1.6000
Close
$ 1.6500
Volume
14665
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

ABIO Stock Chart & Research Data

The ABIO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ABIO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ABIO Due diligence Resources & Stock Charts

The ABIO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ABIO Detailed Price Forecast - CNN Money CNN View ABIO Detailed Summary - Google Finance
Yahoo View ABIO Detailed Summary - Yahoo! Finance Zacks View ABIO Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View ABIO Trends & Analysis - Trade-Ideas Barrons View ABIO Major Holders - Barrons
NASDAQ View ABIO Call Transcripts - NASDAQ Seeking View ABIO Breaking News & Analysis - Seeking Alpha
Spotlight View ABIO Annual Report - CompanySpotlight.com OTC Report View ABIO OTC Short Report - OTCShortReport.com
TradeKing View ABIO Fundamentals - TradeKing Charts View ABIO SEC Filings - Bar Chart
WSJ View Historical Prices for ABIO - The WSJ Morningstar View Performance/Total Return for ABIO - Morningstar
MarketWatch View the Analyst Estimates for ABIO - MarketWatch CNBC View the Earnings History for ABIO - CNBC
StockMarketWatch View the ABIO Earnings - StockMarketWatch MacroAxis View ABIO Buy or Sell Recommendations - MacroAxis
Bullish View the ABIO Bullish Patterns - American Bulls Short Pains View ABIO Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View ABIO Stock Mentions - StockTwits PennyStocks View ABIO Stock Mentions - PennyStockTweets
Twitter View ABIO Stock Mentions - Twitter Invest Hub View ABIO Investment Forum News - Investor Hub
Yahoo View ABIO Stock Mentions - Yahoo! Message Board Seeking Alpha View ABIO Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for ABIO - SECform4.com Insider Cow View Insider Transactions for ABIO - Insider Cow
CNBC View ABIO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ABIO - OTC Markets
Yahoo View Insider Transactions for ABIO - Yahoo! Finance NASDAQ View Institutional Holdings for ABIO - NASDAQ


Stock Charts

FinViz View ABIO Stock Insight & Charts - FinViz.com StockCharts View ABIO Investment Charts - StockCharts.com
BarChart View ABIO Stock Overview & Charts - BarChart Trading View View ABIO User Generated Charts - Trading View


Latest Financial News for ABIO

ARCA biopharma Announces Completion of GENETIC-AF Phase 2B Clinical Trial
Posted on Monday January 08, 2018

--------------------------------------------------------------------------------------------------GENETIC-AF Evaluating Gencaro as Potentially First Genetically-Targeted Treatment for Atrial Fibrillation-------------------------------------------------------------------------------------------------- ...


What You Must Know About ARCA biopharma Inc’s (NASDAQ:ABIO) Major Investors
Posted on Tuesday January 02, 2018

In this article, I’m going to take a look at ARCA biopharma Inc’s (NASDAQ:ABIO) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject amongRead More...


Interested In Healthcare? Why ARCA biopharma Inc (ABIO) May Be The Entry Point
Posted on Friday December 08, 2017

ARCA biopharma Inc (NASDAQ:ABIO), a USD$14.69M small-cap, is a healthcare company operating in an industry, which faces key trends such as rising demand fuelled by an aging population and theRead More...


How Much is ARCA biopharma Inc’s (ABIO) CEO Getting Paid?
Posted on Thursday November 30, 2017

Michael Bristow took the helm as ARCA biopharma Inc’s (NASDAQ:ABIO) CEO and grew market cap to USD$14.69M recently. Understanding how CEOs are incentivised to run and grow their company isRead More...


Which insiders are buying ARCA biopharma, Inc. (ABIO)?
Post Analyst - 7 hours ago
ARCA biopharma, Inc. (NASDAQ:ABIO) marched up 57.14% compared to a 52-week low price of $1.05. The shares were last seen trading -5.71% lower, taking the closing price at $1.65 on 01/15/2018.
What Story Are The Numbers Telling For ARCA biopharma, Inc. (NasdaqCM:ABIO ... - Stock Talker
Analyst rating score for ARCA biopharma, Inc. (ABIO) - Nasdaq Fortune (press release)

ARCA Biopharma: Low Valuation On Past Failures, High Upside And Limited Risk ...
Seeking Alpha - Nov 30, 2016
ARCA Biopharma (NASDAQ: ABIO) is a development stage biotech company that has been beaten down over several decades. Their flagship therapeutic candidate, Gencaro® is a beta-blocker that has seen multiple efficacy issues in outcomes measures ...

Why Arca Biopharma Is A Buy
Seeking Alpha - Jan 14, 2014
The AHA expects 8 million patients will suffer from heart failure (HF) by 2030; atrial fibrillation (AF) will prevail in 12.1 million patients by 2030.

Analysts Give These Stocks Mix Nod: PTC Therapeutics, Inc. (PTCT), ARCA ...
Post Analyst - Jan 15, 2018
PTC Therapeutics, Inc. (NASDAQ:PTCT) recorded a trading volume of 1.3 million shares, above its 90-day volume average of 0.96 million shares.

Enter a stock symbol to view the stock details.